We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Treatment of Recurrent Platinum-Sensitive Epithelial Ovarian Cancer.
- Authors
Liu, Joyce F.; Matulonis, Ursula A.
- Abstract
Ovarian cancer remains a leading cause of cancer death among women, with an estimated 125000 deaths worldwide. Newly diagnosed ovarian cancer is very responsive to first-line platinum-based therapy, but the majority of patients will have disease recurrence. Patients in whom disease recurs more than 6 months after completing prior platinum-based treatment are considered to have platinum-sensitive disease, and questions remain regarding the optimal management of their disease. Many options exist for these patients, including systemic chemotherapy, and in specific circumstances, secondary cytoreductive surgery or radioablative techniques can be considered for patients with localized recurrences and long disease-free intervals. For patients receiving systemic chemotherapy, data from clinical trials suggest that combination platinum-based chemotherapy should be considered in this setting for patients in whom the toxicities would be acceptable, although the optimal regimen remains unclear. Ongoing investigations seek to address the role of secondary cytoreductive surgery, the optimal therapy for recurrent platinum-sensitive disease, the therapeutic potential of non-platinum-based therapies, and the role of biological therapy in this setting.
- Subjects
OVARIAN cancer; CANCER in women; CANCER treatment; CANCER relapse; DRUG therapy; CLINICAL trials; ONCOLOGY; DISEASE management; MEDICAL research
- Publication
European Journal of Clinical & Medical Oncology, 2010, Vol 2, Issue 2, p71
- ISSN
1759-8958
- Publication type
Article